We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Postoperative Delirium in Hip Fracture Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00564434
Recruitment Status : Completed
First Posted : November 28, 2007
Last Update Posted : November 28, 2007
Information provided by:
Ullevaal University Hospital

Brief Summary:
Risk factors for postoperative delirium in hip fracture patients.

Condition or disease

Study Type : Observational
Estimated Enrollment : 364 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Postoperative Delirium in Hip Fracture Patients
Study Start Date : May 2005
Study Completion Date : January 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Delirium/ no-delirium [ Time Frame: 5 days postoperative ]

Secondary Outcome Measures :
  1. Severity of delirium, length of delirium, complications, comorbidity, one-year mortality. [ Time Frame: 5 days postoperative, one year ]

Biospecimen Retention:   Samples With DNA
whole blood, serum

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Study Population
Patients with hip fracture admitted to Ulleval Hospital and Diakonhjemmet Hospital

Inclusion Criteria:

  • hip fracture
  • age 65 or older

Exclusion Criteria:

  • critical ill/ dying
  • aphasia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564434

Ullevaal Hospital
Oslo, Norway
Sponsors and Collaborators
Ullevaal University Hospital

ClinicalTrials.gov Identifier: NCT00564434     History of Changes
Other Study ID Numbers: 1.2005.812
First Posted: November 28, 2007    Key Record Dates
Last Update Posted: November 28, 2007
Last Verified: November 2007

Keywords provided by Ullevaal University Hospital:
risk factors

Additional relevant MeSH terms:
Hip Fractures
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neurocognitive Disorders
Mental Disorders
Femoral Fractures
Fractures, Bone
Wounds and Injuries
Hip Injuries
Leg Injuries